The synthesis of two Ru chloro complexes, Ru(III)Cl(3)(bpea), 1, and cis-fac-Delta-[Ru(II)Cl{(R)-(bpea)}{(S)-(BINAP)}](BF(4)), cis-fac-Delta-(R)-(S)-2, (bpea = N,N-bis(2-pyridylmethyl)ethylamine; (S)-BINAP = 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl), is described. Complex 2 is characterized in solution through UV-vis, cyclic voltammetry (CV), and 1D and 2D NMR spectroscopy. X-ray diffraction analysis indicates that in the solid state it possesses the same structure as in solution, as expected for a low-spin d(6) Ru(II)-type complex. The molecular structure of cis-fac-Delta-(R)-(S)-2, consists of a nonsymmetric complex, where the Ru metal center has a significantly distorted octahedral-type coordination because of the bulkiness of the (S)-BINAP ligand. cis-fac-Delta-(R)-(S)-2 has a remarkable catalytic performance at P = 6.8 atm of H2 and T = 70 degrees C toward the hydrogenation of prochiral double bonds both from efficiency and from stereoselectivity viewpoints. As an example, prochiral olefins of technological interest such as dimethyl itaconate, methyl 2-acetamidoacrylate or methyl 2-acetamidocinnamate are catalytically hydrogenated by cis-fac-Delta-(R)-(S)-2, with conversions higher than 99.9% and ee > 99. Furthermore, cis-fac-Delta-(R)-(S)-2, also catalyzes the selective hydrogenation of beta-keto esters, although the reaction rates are lower than those found with the former substrates.
No takes yet. Share an insight, caveat, or question.
Serrano et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: